T

Travere Therapeutics
D

TVTX

36.280
USD
0.27
(0.75%)
مغلق
حجم التداول
50,965
الربح لكل سهم
-0
العائد الربحي
-
P/E
-35
حجم السوق
3,246,056,024
أصول ذات صلة الأخبار المقالات

العنوان: Travere Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.